Press Releases Experts Criticize New England Journal of Medicine for Conflicts of Interest, Lack of Transparency in Piece on Drug Pricing May 19, 2022
Press Releases FDA Refuses to Impose Serious Sanctions Against Researchers at Minnesota Hospital Who Conducted Unethical High-Risk Experiments May 2, 2022
Press Releases FDA Must Promptly Punish Researchers at Minnesota Hospital Who Conducted Unethical High-Risk Experiments, Require Patients Be Informed Their Rights Were Violated November 17, 2021
Petition to the FDA to Initiate Disqualification Procedures Against Hennepin County Medical Center Researchers and IRB for Unethical High-Risk Clinical Trials November 17, 2021
Public Citizen Calls for Federal Investigation of Serious Regulatory, Ethical Lapses in Reckless Epilepsy Clinical Trial Funded by NIH September 1, 2021
Press Releases Statement: Inspector General’s Decision To Investigate FDA’s Inappropriately Close Collaboration With Biogen on the Alzheimer’s Disease Drug Aducanumab Is Long Overdue August 4, 2021
Press Releases Federal Agencies Must Investigate Serious Regulatory, Ethical Lapses in Reckless Epilepsy Clinical Trial Funded by NIH June 8, 2021
Letters, Testimony & Filings Letter to the OHRP and FDA Calling for Investigations into Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by NIH June 8, 2021
Letters, Testimony & Filings Letter to the NIH Regarding Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by the Agency June 8, 2021